Litcius/Paper detail

Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study

Li Zhang, Zhehai Wang, Jian Fang, Qitao Yu, Baohui Han, Shundong Cang, Gongyan Chen, Xiaodong Mei, Zhixiong Yang, Victoria Jennifer Stefaniak, Yong Lin, Shuyan Wang, Wen Zhang, Luyao Sun, Yunpeng Yang

2022Lung Cancer75 citationsDOI

Topics & Concepts

PemetrexedMedicineOncologyInternal medicineOverall survivalChemotherapyCisplatinLung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and Treatment
Final overall survival data of sintilimab plus pemetrexed and platinum as First-Line treatment for locally advanced or metastatic nonsquamous NSCLC in the Phase 3 ORIENT-11 study | Litcius